Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Calcium signaling pathway 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
2 Calcium signaling pathway 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
3 Calcium signaling pathway 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
4 Calcium signaling pathway 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
5 Calcium signaling pathway 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
6 Calcium signaling pathway 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
7 Central carbon metabolism in cancer 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
8 Central carbon metabolism in cancer 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
9 Central carbon metabolism in cancer 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
10 Central carbon metabolism in cancer 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
11 Central carbon metabolism in cancer 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
12 Central carbon metabolism in cancer 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
13 Endocytosis 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
14 Endocytosis 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
15 Endocytosis 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
16 Endocytosis 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
17 Endocytosis 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
18 Endocytosis 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
19 Gastric cancer 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
20 Gastric cancer 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
21 Gastric cancer 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
22 Gastric cancer 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
23 Gastric cancer 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
24 Gastric cancer 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
25 MAPK signaling pathway 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
26 MAPK signaling pathway 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
27 MAPK signaling pathway 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
28 MAPK signaling pathway 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
29 MAPK signaling pathway 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
30 MAPK signaling pathway 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
31 Pathways in cancer 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
32 Pathways in cancer 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
33 Pathways in cancer 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
34 Pathways in cancer 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
35 Pathways in cancer 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
36 Pathways in cancer 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
37 PI3K-Akt signaling pathway 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
38 PI3K-Akt signaling pathway 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
39 PI3K-Akt signaling pathway 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
40 PI3K-Akt signaling pathway 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
41 PI3K-Akt signaling pathway 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
42 PI3K-Akt signaling pathway 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
43 Prostate cancer 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
44 Prostate cancer 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
45 Prostate cancer 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
46 Prostate cancer 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
47 Prostate cancer 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
48 Prostate cancer 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
49 Rap1 signaling pathway 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
50 Rap1 signaling pathway 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
51 Rap1 signaling pathway 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
52 Rap1 signaling pathway 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
53 Rap1 signaling pathway 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
54 Rap1 signaling pathway 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
55 Ras signaling pathway 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
56 Ras signaling pathway 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
57 Ras signaling pathway 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
58 Ras signaling pathway 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
59 Ras signaling pathway 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
60 Ras signaling pathway 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
61 Regulation of actin cytoskeleton 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
62 Regulation of actin cytoskeleton 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
63 Regulation of actin cytoskeleton 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
64 Regulation of actin cytoskeleton 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
65 Regulation of actin cytoskeleton 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
66 Regulation of actin cytoskeleton 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬
67 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR2 💬 Catequentinib 💬 Anlotinib 1件: 85 💬
68 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR2 💬 Infigratinib 💬 Infigratinib 1件: 276 💬
69 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR2 💬 Infigratinib phosphate 💬 Infigratinib 1件: 276 💬
70 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR2 💬 Nintedanib esylate 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
71 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR2 💬 Nintedanib 💬 Nintedanib 7件: 51, 84, 85, 89, 227, 228, 331 💬
72 Signaling pathways regulating pluripotency of stem cells 💬
1件: FGFR2 💬 Palifermin 💬 Palifermin 6件: 13, 36, 38, 39, 65, 96 💬